[
  {
    "ts": "2026-02-23T12:08:58+00:00",
    "headline": "Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story?",
    "summary": "In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 million for the year, and reaffirmed its 2026 revenue guidance of US$5.16–US$5.25 billion. The company also completed a US$499.99 million share repurchase program and highlighted strong uptake of its 15-day G7 sensor, underscoring management’s confidence in product adoption and capital...",
    "url": "https://finance.yahoo.com/news/did-dexcoms-dxcm-strong-2025-120858722.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "edff3acd-2c27-3877-b996-4fe28ce68531",
      "content": {
        "id": "edff3acd-2c27-3877-b996-4fe28ce68531",
        "contentType": "STORY",
        "title": "Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story?",
        "description": "",
        "summary": "In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 million for the year, and reaffirmed its 2026 revenue guidance of US$5.16–US$5.25 billion. The company also completed a US$499.99 million share repurchase program and highlighted strong uptake of its 15-day G7 sensor, underscoring management’s confidence in product adoption and capital...",
        "pubDate": "2026-02-23T12:08:58Z",
        "displayTime": "2026-02-23T12:08:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/did-dexcoms-dxcm-strong-2025-120858722.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/did-dexcoms-dxcm-strong-2025-120858722.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T20:40:14+00:00",
    "headline": "DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership",
    "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95. The analyst maintained his Buy rating on the stock. Plovanic noted that fourth-quarter results and 2026 outlook […]",
    "url": "https://finance.yahoo.com/news/dexcom-inc-dxcm-continues-focus-204014108.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1fad4ef4-07a8-3363-9d02-d4d47b549cea",
      "content": {
        "id": "1fad4ef4-07a8-3363-9d02-d4d47b549cea",
        "contentType": "STORY",
        "title": "DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership",
        "description": "",
        "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95. The analyst maintained his Buy rating on the stock. Plovanic noted that fourth-quarter results and 2026 outlook […]",
        "pubDate": "2026-02-23T20:40:14Z",
        "displayTime": "2026-02-23T20:40:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/2c011ea425775dc6c3477de29681aed9",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sBdrelMuH73xo3M1E8FDxw--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/2c011ea425775dc6c3477de29681aed9.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aH.8zxyXVdvySElX45xocA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/2c011ea425775dc6c3477de29681aed9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-inc-dxcm-continues-focus-204014108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-inc-dxcm-continues-focus-204014108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]